At a glance
The February 27, 2023, Laboratory Outreach Communication System (LOCS) call included updates on the SARS-CoV-2 variants, H5 influenza situation, and the FDA's Resiliency Program.
Agenda
Welcome: Jasmine Chaitram, ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of Laboratory Systems
SARS-CoV-2 Variants Update: Natalie Thornburg, ÐÇ¿ÕÓéÀÖ¹ÙÍø Division of Viral Diseases
H5 Situation Update: John Barnes, ÐÇ¿ÕÓéÀÖ¹ÙÍø Influenza Division
FDA's Resiliency Program: Tammy Beckham, US Food and Drug Administration